DEPRESSION NORMAL MOOD RECOVERY OR REMISSION EPISODE OF DEPRESSION TIME 6 - 24 months 5-1 Stahl S M,...
-
Upload
heather-harris -
Category
Documents
-
view
215 -
download
0
Transcript of DEPRESSION NORMAL MOOD RECOVERY OR REMISSION EPISODE OF DEPRESSION TIME 6 - 24 months 5-1 Stahl S M,...
DEPRESSION
NORMAL MOOD
RECOVERY OR REMISSION
EPISODE OF DEPRESSIONEPISODE OF DEPRESSION
TIME6 - 24 months
5-1 Stahl S M, Essential Psychopharmacology (2000)
acute 6 - 12 weeks
continuation4-9 months
maintenance1 or more years
REMISSION
RECOVERY
DEPRESSION
NORMAL MOOD
100%
5-3 Stahl S M, Essential Psychopharmacology (2000)
TIME
5-4 Stahl S M, Essential Psychopharmacology (2000)
acute 6 - 12 weeks
continuation4-9 months
maintenance1 or more years
TIME
DEPRESSION
NORMAL MOOD RELAPSE RECURRENCE
5-5 Stahl S M, Essential Psychopharmacology (2000)
DEPRESSION
NORMAL MOOD
MANIA
HYPOMANIA
MIXED EPISODE
12 months
DEPRESSION
NORMAL MOOD
RAPID CYCLINGRAPID CYCLING
5-6 Stahl S M, Essential Psychopharmacology (2000)
2+ years
DEPRESSION
NORMAL MOOD
DYSTHYMIADYSTHYMIA
5-7 Stahl S M, Essential Psychopharmacology (2000)
6 - 24 months2+ years
DEPRESSION
NORMAL MOOD
DYSTHYMIA PARTIAL RECOVERY
DOUBLE DEPRESSIONDOUBLE DEPRESSION
5-8 Stahl S M, Essential Psychopharmacology (2000)
5-9 Stahl S M, Essential Psychopharmacology (2000)
8 weeks
DEPRESSION
NORMAL MOOD
67% RESPONDERS
MEDICATIONMEDICATION
medication started
33% NON-RESPONDERS
5-10 Stahl S M, Essential Psychopharmacology (2000)
8 weeks
DEPRESSION
NORMAL MOOD
33% RESPONDERS
PLACEBOPLACEBO
placebo started
67% NON-RESPONDERS
5-11 Stahl S M, Essential Psychopharmacology (2000)
DEPRESSION
NORMAL MOOD
50% continue response
PLACEBO PLACEBO SUBSTITUTIONSUBSTITUTION
antidepressant treatment
placebo
50% relapse
5-12 Stahl S M, Essential Psychopharmacology (2000)
DEPRESSION
NORMAL MOOD
90% continue response
DRUG DRUG CONTINUATIONCONTINUATION
antidepressant treatment
10% relapse
MAO enzyme destroying neurotransmitter
monoamine neurotransmitter
NORMAL STATE -- no depression
MONOAMINE HYPOTHESIS
5-13 5-14
Stahl S M, Essential Psychopharmacology (2000)
DEPRESSION -- caused by neurotransmitter deficiency
Increase in neurotransmitters causes return to normal state
MAO inhibitor blocks the enzyme from destroying monoamine neurotransmitter
reuptake pump blocked by antidepressant
5-15 5-16
Stahl S M, Essential Psychopharmacology (2000)
NE (norepinephrine)
tyrosine transporter
TYR
TOH
DOPA
DDC DA
DBH
NOREPINEPHRINE IS PRODUCED
5-17 Stahl S M, Essential Psychopharmacology (2000)
NOREPINEPHRINE IS DESTROYED
COMT destroys NEnorepinephrine
transporter
MAO
5-18 Stahl S M, Essential Psychopharmacology (2000)
NOREPINEPHRINE RECEPTORS
presynaptic alpha 2 autoreceptor
postsynaptic alpha 2
receptorpostsynaptic beta 1 receptor
alpha 1 receptor
5-19 Stahl S M, Essential Psychopharmacology (2000)
terminal alpha 2 autoreceptor
somatodendritic alpha 2
autoreceptor
5-20 Stahl S M, Essential Psychopharmacology (2000)
NE occupying somatodendritic autoreceptor causes a decrease in firing and a decrease of NE release
5-21 Stahl S M, Essential Psychopharmacology (2000)
NE
NE occupying terminal alpha 2 receptor halts release of NE
5-22 Stahl S M, Essential Psychopharmacology (2000)
NE
tyrosine transporter
TOH
TYR
DOPA
DDC
DA (Dopamine)
DOPAMINE IS PRODUCED
5--31 Stahl S M, Essential Psychopharmacology (2000)
COMT destroys NE
dopamine transporter
MAO
DOPAMINE IS DESTROYED
5--32 Stahl S M, Essential Psychopharmacology (2000)
DOPAMINE RECEPTORS
presynaptic autorecptor
D1 D2 D3 D4 D5
dopamine transporter
5--33 Stahl S M, Essential Psychopharmacology (2000)
5HT (Serotonin)
SEROTONIN IS PRODUCEDtryptophan transporter
TRY-OH
5HTP
AAADC
Tryptophan
5--34 Stahl S M, Essential Psychopharmacology (2000)
serotonin transporter
MAO
SEROTONIN IS DESTROYED
5--35 Stahl S M, Essential Psychopharmacology (2000)
SEROTONIN RECEPTORS
alpha 2 hetero receptor
5HT1D autoreceptor
5HT1A
serotonin transporter
5HT2A5HT2C
5HT3 5HT45HTX
5HTY
5HTZ
5--36 Stahl S M, Essential Psychopharmacology (2000)
norepinephrine
serotonin
alpha 2 hetero receptor
serotonin neuron
5--43 Stahl S M, Essential Psychopharmacology (2000)
brake
accelerator
Locus Coeruleus
NE-5HT Interactions
5--47 Stahl S M, Essential Psychopharmacology (2000)
serotonin neuron
presynaptic alpha 2 autoreceptor
postsynaptic alpha 2 hetero receptor
presynaptic alpha 2 autoreceptor alpha 1
receptor
norepinephrine neuron
5--48 Stahl S M, Essential Psychopharmacology (2000)
5HT accelerator
5HT brake
Monoamine Receptor Hypothesis of DepressionMonoamine Receptor Hypothesis of Depression
Normal functioning
Decrease in NT
Receptors up-regulate due to lack of NT
5--60 5-61 6-62
Stahl S M, Essential Psychopharmacology (2000)
substance P release
pain and swelling
substance P release
5--65 Stahl S M, Essential Psychopharmacology (2000)
= substance P
hypothalamus
amydala and limbic areas
dopamine centers norepinephrine
centers
Neurokinin Hypothesis of Emotional Malfunctioning Corollary: Blockng the Appropriate Neurokinin
Receptor will Reduce Emotional Distress
5--66 Stahl S M, Essential Psychopharmacology (2000)
substance P
Neurokinin A (NK-A)
Neurokinin B (NK-B)
Arg Pro Lys Gln Gln Phe Phe Gly Leu Met NH2
Gly Leu Met NH2
Gly Leu Met NH2
Val
Val
SerAspThrLysHis
Asp PheHisMetAsp
5--67 Stahl S M, Essential Psychopharmacology (2000)
PPT-A gene
PPT-A mRNA
signal peptidase
endoplasmic reticulum
converting enzyme
substance P
NK-1 receptor
5--68 Stahl S M, Essential Psychopharmacology (2000)
PPT-A spliced mRNA
PPT-A protein
PT-A
PPT-A gene
PPT-A mRNA
signal peptidase
endoplasmic reticulum
converting enzyme
substance P
NK-1 receptor
5--69 Stahl S M, Essential Psychopharmacology (2000)
PPT-A spliced mRNA
PPT-A protein
PT-A
PPT-A gene
PPT-A mRNA
signal peptidase
endoplasmic reticulum
converting enzyme
substance P
NK-1 receptor
PPT-A spliced mRNA
5--70 Stahl S M, Essential Psychopharmacology (2000)
PPT-A protein
PT-A
PPT-A gene
PPT-A mRNA
signal peptidase
endoplasmic reticulum
converting enzyme
NK-A
NK-2 receptor
5--71 Stahl S M, Essential Psychopharmacology (2000)
PPT-A spliced mRNA
PPT-A protein
PT-A
PPT-A gene
PPT-A mRNA
signal peptidase
endoplasmic reticulum
converting enzyme
NK-A
NK-2 receptor
PPT-A spliced mRNA
5--72 Stahl S M, Essential Psychopharmacology (2000)
PPT-A protein
PT-A